EMPLOYMENT AGREEMENTEmployment Agreement • October 17th, 2017 • Adgero Biopharmaceuticals Holdings, Inc. • Pharmaceutical preparations • New Jersey
This EMPLOYMENT AGREEMENT (this “Agreement”), dated as of October 11, 2017 is by and between ADGERO BIOPHARMACEUTICALS HOLDINGS, INC., a Delaware corporation (the “Company”) and John Liatos (the “Employee”).
ADGERO BIOPHARMACEUTICALS HOLDINGS, INC. Princeton, NJ 08540 WARRANT AGENT AGREEMENTWarrant Agent Agreement • October 17th, 2017 • Adgero Biopharmaceuticals Holdings, Inc. • Pharmaceutical preparations • New York
This Warrant Agent Agreement, dated as of August 14, 2017 (the “Agreement”), is entered into by and among Aegis Capital Corp. (the “Warrant Agent”) and Adgero Biopharmaceuticals Holdings, Inc. (“Adgero”).
SECOND AMENDMENT OF REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • October 17th, 2017 • Adgero Biopharmaceuticals Holdings, Inc. • Pharmaceutical preparations • New York
This Second Amendment of Registration Rights Agreement (this “Second Amendment”) is made and entered into effective as of the Effective Date (as defined below) between Adgero Biopharmaceuticals Holdings, Inc., a Delaware corporation (“Adgero,” or the “Company”), and the other parties to the Registration Rights Agreement, dated April 8, 2016, as amended (the “Agreement”), consisting of investors in the PPO (as defined below), certain bridge note investors who exchanged their bridge notes for securities identical to those sold in the PPO, and holders of replacement warrants (“Replacement Warrants”) that were issued in exchange for warrants to purchase shares of common stock of Adgero Biopharmaceuticals, Inc., a Delaware corporation, in connection with the Merger (as defined in the Agreement) (each, a “Purchaser” and collectively, the “Purchasers”).
